BHARAT BIOTECH
No Impact of WHO Action on COVID-19 Vaccine Covaxin, Have Not Supplied to Any UN Agency, Says Bharat Biotech
Bharat Biotech Enters into Partnership with Spanish Biopharmaceutical Firm Biofabri for Tuberculosis Vaccine
Union Budget 2022 Outlay in Health Sector, Vaccine Self-Reliance Has Helped Biotech Industry, Says Bharat Biotech Chairman Dr Krishna Ella
COVID-19 Vaccine for Children: Ensure Only Covaxin Is Given to 15–18 Group, Says Bharat Biotech
COVAXIN Booster Dose Trial Demonstrates Long-Term Safety With No Serious Adverse Events, Says Bharat Biotech
Bharat Biotech Gets Approval to Conduct Phase III Trial of COVID-19 Intranasal Vaccine as Booster Dose
COVID-19 Vaccination for Teenagers: Over 16 Lakh Vaccinated on Day 1 of Children Aged 15-18 Years So Far
Covaxin for Children: Robust Safety, Immunogenicity in 2-18 Year Old Volunteers, Says Study
Google Trends